Outlook on Electrolux Revised to Positive From Stable; BBB+/A-2 Ratings Affirmed Jun 00

  • ID: 2035483
  • June 2000
  • Standard & Poors
1 of 3

LONDON (Standard & Poor's CreditWire) June 29, 2000--As a result of Electrolux AB's strengthening financial and business profile amid ongoing cost reductions and streamlining of the group, Standard & Poor's today revised its outlook on the company to positive from stable. At the same time, Standard & Poor's affirmed its triple-'B'-plus long-term and 'A-2' short-term corporate credit ratings on Electrolux, which reflecting the company's position as one of the leading companies within the global appliance industry. The 'A-2' commercial paper rating on White Consolidated Holdings Inc., which is guarantee by Elextrolux is also affirmed. A complete list of ratings is available on RatingsDirect, Standard & Poor's Web-based credit analysis system, or by calling the Standard & Poor's ratings desk on...

Companies mentioned in this report are: Electrolux AB
Action: Outlook Revised

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Electrolux AB

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.